Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication

Hong Kong Med J. 2009 Jun;15(3 Suppl 4):28-31.

Authors

M L He¹, B J Zheng, Y Chen, K L Wong, J D Huang, M C Lin, K Y Yuen, J J Y Sung, H F Kung

Affiliation

¹ Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong SAR, China. mlhe@cuhk.edu.hk

PMID: 19509435

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adenoviridae / genetics
Animals
Antiviral Agents / pharmacology
Cells, Cultured
Kidney / cytology
Macaca mulatta
RNA / biosynthesis*
RNA / genetics
RNA, Small Interfering / biosynthesis*
RNA, Small Interfering / genetics
RNA, Small Interfering / pharmacology*
Severe acute respiratory syndrome-related coronavirus / drug effects*
Severe acute respiratory syndrome-related coronavirus / genetics
Severe acute respiratory syndrome-related coronavirus / physiology
Virus Replication / drug effects*

Substances

Antiviral Agents
RNA, Small Interfering
RNA, recombinant
RNA